On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.

Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s Section 1498 appeal If the $1.3 billion ...

Arbutus Biopharma (NasdaqGS:ABUS) has been added to the Russell 2000 Growth Defensive and Russell 2000 Defensive Indexes. At ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

In this article we will take a look at whether hedge funds think Arbutus Biopharma Corp (NASDAQ:ABUS) is a good investment right now. We check hedge fund and billionaire investor sentiment before ...

Fintel reports that on July 6, 2023, JMP Securities reiterated coverage of Arbutus Biopharma (NASDAQ:ABUS) with a Market Outperform recommendation. As of July 6, 2023, the average one-year price ...